Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Johnson

Showing results (21-30 of 105) with videos related to

Pageof 11
Sort By:
Cancer Research|June 3, 2006
Sulforaphane causes autophagy to inhibit release of cytochrome C and apoptosis in human prostate cancer cellsAnna Herman-Antosiewicz, Daniel E Johnson, Shivendra V Singh
Cancer|November 29, 2024
Social capital as a catalyst for gender inequality: A scoping review of networking disparities in academic medicineJacquelyn K Callander, Daniel E Johnson, Jennifer R Grandis
Cancer Metastasis Reviews|September 4, 2017
EGFR-targeted therapies in the post-genomic eraMary Jue Xu, Daniel E Johnson, Jennifer R Grandis
Expert Opinion on Emerging Drugs|November 1, 2018
An update: emerging drugs to treat squamous cell carcinomas of the head and neckYoon Se Lee, Daniel E Johnson, Jennifer R Grandis
Annals of Translational Medicine|November 22, 2016
A sensible approach to targeting STAT3-mediated transcriptionNeil E Bhola, Daniel E Johnson, Jennifer R Grandis
Trends in Cancer|May 1, 2018
New Therapies in Head and Neck CancerRodell T Santuray, Daniel E Johnson, Jennifer R Grandis
Advances in Biological Regulation|June 17, 2014
STAT transcription factors in normal and cancer stem cellsKathleen A Dorritie, Robert L Redner, Daniel E Johnson
Advances in Biological Regulation|September 29, 2025
Conventional and alternative approaches for targeting PIK3CA and PTEN alterations in head and neck, breast, and other cancersJovanka Gencel-Augusto, Jennifer R Grandis, Daniel E Johnson
Cancer Research|October 2, 2023
To Tip or Not to Tip: A New Combination for Precision Medicine in Head and Neck CancerRex H Lee, Daniel E Johnson, Jennifer R Grandis
Cancer Biology & Medicine|July 7, 2026
NSAIDs for PI3K-altered head and neck cancer: a biomarker-driven therapeutic opportunityJovanka Gencel-Augusto, Daniel E Johnson, Jennifer R Grandis
Pageof 11

Showing results (21-30 of 105) with videos related to

Sort By:
Pageof 11
Cancer Research|June 3, 2006
Sulforaphane causes autophagy to inhibit release of cytochrome C and apoptosis in human prostate cancer cellsAnna Herman-Antosiewicz, Daniel E Johnson, Shivendra V Singh
Cancer|November 29, 2024
Social capital as a catalyst for gender inequality: A scoping review of networking disparities in academic medicineJacquelyn K Callander, Daniel E Johnson, Jennifer R Grandis
Cancer Metastasis Reviews|September 4, 2017
EGFR-targeted therapies in the post-genomic eraMary Jue Xu, Daniel E Johnson, Jennifer R Grandis
Expert Opinion on Emerging Drugs|November 1, 2018
An update: emerging drugs to treat squamous cell carcinomas of the head and neckYoon Se Lee, Daniel E Johnson, Jennifer R Grandis
Annals of Translational Medicine|November 22, 2016
A sensible approach to targeting STAT3-mediated transcriptionNeil E Bhola, Daniel E Johnson, Jennifer R Grandis
Trends in Cancer|May 1, 2018
New Therapies in Head and Neck CancerRodell T Santuray, Daniel E Johnson, Jennifer R Grandis
Advances in Biological Regulation|June 17, 2014
STAT transcription factors in normal and cancer stem cellsKathleen A Dorritie, Robert L Redner, Daniel E Johnson
Advances in Biological Regulation|September 29, 2025
Conventional and alternative approaches for targeting PIK3CA and PTEN alterations in head and neck, breast, and other cancersJovanka Gencel-Augusto, Jennifer R Grandis, Daniel E Johnson
Cancer Research|October 2, 2023
To Tip or Not to Tip: A New Combination for Precision Medicine in Head and Neck CancerRex H Lee, Daniel E Johnson, Jennifer R Grandis
Cancer Biology & Medicine|July 7, 2026
NSAIDs for PI3K-altered head and neck cancer: a biomarker-driven therapeutic opportunityJovanka Gencel-Augusto, Daniel E Johnson, Jennifer R Grandis
Pageof 11